Steven Coca, DO, outlines the importance of early identification of kidney disease in patients with diabetes and the potential to use artificial intelligence for this purpose.
Weight gain after smoking cessation partially attenuates the beneficial effect on cardiovascular morbidity.
Researchers assessed the efficacy and safety of different antihyperglycemic agents in patients with nonalcoholic fatty liver disease.
In patients with type 2 diabetes, treatment with liraglutide does not affect bone resorption and preserves hip bone mineral density, even with weight loss.
The FDA has approved a new indication for Ozempic (semaglutide; Novo Nordisk) injection to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
Providing nonsurgical periodontal treatment to patients with type 2 diabetes and periodontitis may significantly reduce tooth loss and diabetes-related microvascular diseases via improved glycemic control.
Bariatric surgery is associated with weight loss and remission of type 2 diabetes and dyslipidemia at five years postsurgery.
In patients with diabetes and high cardiovascular risk, hemoglobin A1c is strongly associated with cardiovascular outcomes.
For those looking for a quick fix, the HMR Program was ranked number one for fast weight loss.
Habitual physical activity, such as walking or gardening, may decrease fasting GLP-1 concentrations and increase glucose-stimulated GLP-1 responses independent of insulin sensitivity.
